96 related articles for article (PubMed ID: 3074745)
1. HLA antigens and the antibody response after vaccination to hepatitis B.
Matej H; Nowakowska B; Pacyńska J; Gładysz A; Zalewska M; Simon K
Arch Immunol Ther Exp (Warsz); 1988; 36(4):505-9. PubMed ID: 3074745
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
3. Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes.
Zhang SY; Gu HX; Li D; Yang SF; Zhong ZH; Li XK; Jin X
Jpn J Infect Dis; 2006 Dec; 59(6):353-7. PubMed ID: 17186951
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of histocompatibility groups to chronic HBV infections].
Hacibektaşoğlu A; Barut A; Inal A
Mikrobiyol Bul; 1993 Jul; 27(3):241-8. PubMed ID: 8361414
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of hepatitis B--HLA DR/DQ in HBs Ag nonresponder].
Ouchi E; Hoshino A; Miura T; Nagahara N; Kudo Y; Tamura M
Rinsho Byori; 1989 Nov; 37(11):1193-9. PubMed ID: 2601078
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India.
Das K; Gupta RK; Kumar V; Singh S; Kar P
Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656
[TBL] [Abstract][Full Text] [Related]
7. Correlation between immunogenetic markers and "in vivo" response to the german hepatitis B vaccine.
Höher PG; Vögeler U; Schröder G; Werner J; Doxiadis I; Grosse-Wilde H
Dev Biol Stand; 1983; 54():171-8. PubMed ID: 6228456
[TBL] [Abstract][Full Text] [Related]
8. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
[TBL] [Abstract][Full Text] [Related]
9. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
Lin HH; Liao HW; Lin SK; Wang LY
Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
[TBL] [Abstract][Full Text] [Related]
10. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Shane Pankratz V; Jacobsen SJ; Poland GA
Vaccine; 2004 May; 22(15-16):1914-20. PubMed ID: 15121303
[TBL] [Abstract][Full Text] [Related]
11. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
12. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients.
Caillat-Zucman S; Gimenez JJ; Albouze G; Lebkiri B; Naret C; Jungers P; Bach JF
Kidney Int Suppl; 1993 Jun; 41():S157-60. PubMed ID: 8320910
[TBL] [Abstract][Full Text] [Related]
13. [Immune response to the vaccine (Hepavax B) against the B virus].
Pérez V; Fay O
Acta Gastroenterol Latinoam; 1983; 13(4):675-82. PubMed ID: 6680259
[TBL] [Abstract][Full Text] [Related]
14. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
15. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects.
Ricci G; Colombo C; Ghiazza B; Porta C; Moroni M; Illeni MT
Cancer Lett; 1995 Nov; 98(1):121-5. PubMed ID: 8529200
[TBL] [Abstract][Full Text] [Related]
16. [HLA antigens in cleft lip-palate patients].
Wegener S; Jakubik E; Schmidt M
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(5):378-82. PubMed ID: 2135244
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies].
Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R
Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
